Oxford Biomedica plc

Informe acción LSE:OXB

Capitalización de mercado: UK£426.7m

Oxford Biomedica Dirección

Dirección controles de criterios 2/4

Oxford Biomedica's CEO is Frank Mathias, appointed in Mar 2023, has a tenure of 1.67 years. total yearly compensation is £520.00K, comprised of 88.1% salary and 11.9% bonuses, including company stock and options. directly owns 0.019% of the company’s shares, worth £80.99K. The average tenure of the management team and the board of directors is 1.2 years and 3.7 years respectively.

Información clave

Frank Mathias

Chief Executive Officer (CEO)

UK£520.0k

Compensación total

Porcentaje del salario del CEO88.1%
Permanencia del CEO1.7yrs
Participación del CEO0.02%
Permanencia media de la dirección1.2yrs
Promedio de permanencia en la Junta Directiva3.7yrs

Actualizaciones recientes de la dirección

Recent updates

Is Oxford Biomedica (LON:OXB) Using Debt Sensibly?

Oct 19
Is Oxford Biomedica (LON:OXB) Using Debt Sensibly?

Oxford Biomedica plc (LON:OXB) Not Doing Enough For Some Investors As Its Shares Slump 28%

Aug 23
Oxford Biomedica plc (LON:OXB) Not Doing Enough For Some Investors As Its Shares Slump 28%

Is Oxford Biomedica plc (LON:OXB) Expensive For A Reason? A Look At Its Intrinsic Value

Feb 15
Is Oxford Biomedica plc (LON:OXB) Expensive For A Reason? A Look At Its Intrinsic Value

Is Oxford Biomedica (LON:OXB) Using Too Much Debt?

Oct 06
Is Oxford Biomedica (LON:OXB) Using Too Much Debt?

Investors Shouldn't Be Too Comfortable With Oxford Biomedica's (LON:OXB) Robust Earnings

May 02
Investors Shouldn't Be Too Comfortable With Oxford Biomedica's (LON:OXB) Robust Earnings

We're Not Worried About Oxford Biomedica's (LON:OXB) Cash Burn

Jun 29
We're Not Worried About Oxford Biomedica's (LON:OXB) Cash Burn

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Frank Mathias en comparación con los beneficios de Oxford Biomedica?
FechaCompensación totalSalarioIngresos de la empresa
Jun 30 2024n/an/a

-UK£142m

Mar 31 2024n/an/a

-UK£150m

Dec 31 2023UK£520kUK£458k

-UK£157m

Compensación vs. Mercado: Frank's total compensation ($USD671.88K) is below average for companies of similar size in the UK market ($USD1.01M).

Compensación vs. Ingresos: Insufficient data to compare Frank's compensation with company performance.

CEO

Frank Mathias (62 yo)

1.7yrs

Permanencia

UK£520,000

Compensación

Dr. Frank Mathias is Chief Executive Officer and Director of Oxford Biomedica plc from March 27, 2023. Dr. Mathias was the Chief Executive Officer of Rentschler Biopharma SE from April 2016 until March 202...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Frank Mathias
CEO & Director1.7yrsUK£520.00k0.019%
£ 81.0k
Lucinda Crabtree
CFO & Directorless than a yearsin datossin datos
Thierry Cournez
Chief Operating Officer1.1yrssin datossin datos
Sophia Bolhassan
Head of Investor Relationsno datasin datossin datos
Natalie Walter
General Counsel & Company Secretary5.5yrssin datossin datos
Lisa James
Chief People Officer2.6yrssin datossin datos
Kyriacos Mitrophanous
Chief Innovation Officerless than a yearsin datossin datos
Kati Hudson
Head of Intellectual Property and Contractsno datasin datossin datos
Sebastien Ribault
Chief Business Officer2yrssin datossin datos
Mark Caswell
Site Head of UK Operations1.3yrssin datossin datos
Stephanie Colloud
Site Head & GM of France Operationsless than a yearsin datossin datos
Sabine Sydow
Chief of Staffless than a yearsin datossin datos

1.2yrs

Permanencia media

51yo

Promedio de edad

Equipo directivo experimentado: OXB's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Frank Mathias
CEO & Director1.7yrsUK£520.00k0.019%
£ 81.0k
Lucinda Crabtree
CFO & Directorless than a yearsin datossin datos
Frederic Doliveux
Non-Executive Chair4.4yrsUK£225.00k0.35%
£ 1.5m
William Langston
Member of Scientific Advisory Boardno datasin datossin datos
Peter Stern
Member of Scientific Advisory Boardno datasin datossin datos
Krystof Bankiewicz
Member of Scientific Advisory Boardno datasin datossin datos
Leone Patterson
Independent Non-Executive Director1.5yrsUK£87.00k0.012%
£ 50.4k
Heather Preston
Independent Non-Executive Director6.7yrsUK£140.00k0.017%
£ 74.1k
Dame Davies
Senior Independent Director3.7yrsUK£73.00k0.00095%
£ 4.1k
Stuart Henderson
Independent Vice Chair8.4yrsUK£85.00k0.010%
£ 44.0k
Robert Ghenchev
Non-Executive Director5.4yrssin datossin datos
Namrata Patel
Independent Non-Executive Director2.6yrsUK£65.00k0.0087%
£ 37.1k

3.7yrs

Permanencia media

62yo

Promedio de edad

Junta con experiencia: OXB's board of directors are considered experienced (3.7 years average tenure).